Rabivac Vet Vaccine

Listing ID #1579220

Get Latest Price

Supply Type Supplier
Preferred Buyer Location All over the world

Keeping up with the latest trends, we strive to achieve utmost customer satisfaction. We, as a Supplier and Exporter of Rabivac Vet Vaccine, deliver immaculate quality to our customers. The raw....

View More Details

Send Enquiry

Product Details

Keeping up with the latest trends, we strive to achieve utmost customer satisfaction. We, as a Supplier and Exporter of Rabivac Vet Vaccine, deliver immaculate quality to our customers. The raw material used in the manufacturing is of high-grade quality. Our vendors assure us in terms of meeting the standards of quality set by industry. For our valued customers, we make quick delivery of the vaccine at their doorstep.

Description : Rabivac Vet contains tissue culture adapted rabies virus (strain PV 11) propagated on BHK-21 cells. The virus is inactivated with bromoethylenimine (BEI), a proven Aziridine compound and adjuvanted with Aluminium Hydroxide Gel. Each dose of 1 ml of Rabivac Vet provides ≥2.5 IU potency meeting the WHO standards.
Indications : Rabivac Vet is recommended for immunization of dogs and other domestic animals against rabies infection, both for Prophylactic and Post-bite therapy.
Administration :

The vaccine vial should be thoroughly shaken before withdrawal of contents.
Sterile syringe & needle should be used.
Hygienic and sterile Precautions should be followed while administration of vaccine.

Route : Subcutaneous / Intramuscular

Dosage :

1 ml to dogs, cattle and other species of animals.
Primary Vaccination: Above 3 months of age.
If given below 3 months of age, booster dose should be at 3 months of age with a gap of 21 days.
As per WHO, annual vaccination is recommended in endemic areas.

Post-bite therapy : The following schedule of vaccination is suggested for Post-bite therapy.

1st dose - 0 day i.e., the day of 1st injection
2nd dose - 3rd day
3rd dose - 7th day
4th dose - 14th day
5th dose - 28th day
6th dose - 90th day (booster dose - Optional)

Post vaccination reactions/Side effects : Generally no adverse reactions are noticed. Occasionally a palpable swelling may occur at the site of injection that is transient in nature.

Storage and Transport :

The vaccine should be stored and transported between 2 and 8 °C.
At no stage should the vaccine be permitted to freeze.

Presentation :

1 ml - Single dose vial
5 ml & 10 ml - Multi-dose vial

Company Details

Brilliant bio pharma limited (bbpl) is a member company of 226 million us$ tgv conglomerate engaged in manufacture of veterinary biologicals and medicines. The group has diverse activities like industrial chemicals, aquaculture, salt , power, health care, hospitality industry, personal care products, veterinary biologicals and medicines. The group has to its credit the awards like “national award for safety”, “national award for environment and the “national award for r&d”.
Brilliant bio pharma limited was set up in 1988 at hyderabad to manufacture and market veterinary biologicals & medicines with the state-of-art facility. All the initial vaccine batches are tested and certified by indian veterinary research institute (ivri). The manufacturing facility is accredited with who gmp and iso 9001-2008 certification.
Mrs. Mourya boda has taken up the reigns of chairperson & managing director, brilliant bio pharma limited in 2005. She holds bachelor’s degree in law and masters in business management. She was the chairperson for young ficci ladies organization, hyderabad chapter (a division of the federation of indian chambers of commerce and industry (ficci)) during the year 2012-2013.
The r&d wing is certified by the nodal agency for certification of industrial r&d facilities in india, viz., department of science & industrial research (dsir), government of india.
The vaccines are manufactured using modern technology. The vaccines are tested and certified for their safety, sterility and potency as per various pharmacopeial standards.
Our niche products are foot and mouth disease vaccine (fmd) and rabies vaccine. The installed capacity of fmd vaccine is 100 million trivalent doses and the expansion plan for 200 million trivalent doses is in the process. The installed capacity of other bacterial vaccines and rabies vaccine is in excess of 55 million doses.
In addition to the vaccines, our product profile includes animal health products such as antibiotics and antibacterials, analgesics & antipyretics, dewormers, ecto parasiticides, feed additives and galactogogues, etc. Bbpl has the capability to formulate any animal health products (medicines) to suit the live stock requirement of the given country.
Bbpl has strong presence in domestic and international market. The products are registered and being exported to various countries in south east asia, gulf, middle east, far east, cis countries, africa and latin america.